The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource. Please follow the citation guidelines if you are using it.
×
TSP1292-CMap - NLT_B: Toxicogenomic signatures after exposure to oxaliplatin TSA9810-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin TSA9820-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin TSF13836-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 49.99 µM 1 subfactor(s) TSF13837-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 24.98 µM 1 subfactor(s) TSF13838-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 12.46 µM 1 subfactor(s) TSF13839-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 6.24 µM 1 subfactor(s) TSF13840-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 3.12 µM 1 subfactor(s) TSF13841-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 1.6 µM 1 subfactor(s) TSF13842-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.8 µM 1 subfactor(s) TSF13843-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.39 µM 1 subfactor(s) TSF13844-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.2 µM 1 subfactor(s) TSF13845-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.1 µM 1 subfactor(s) TSF13846-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.05 µM 1 subfactor(s) TSF13946-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 49.99 µM 1 subfactor(s) TSF13947-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 24.98 µM 1 subfactor(s) TSF13948-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 12.46 µM 1 subfactor(s) TSF13949-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 6.24 µM 1 subfactor(s) TSF13950-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 3.12 µM 1 subfactor(s) TSF13951-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 1.6 µM 1 subfactor(s) TSF13952-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.8 µM 1 subfactor(s) TSF13953-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.39 µM 1 subfactor(s) TSF13954-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.2 µM 1 subfactor(s) TSF13955-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.1 µM 1 subfactor(s) TSF13956-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.05 µM 1 subfactor(s) TSS13839-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 49.99 µM TSS13840-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 24.98 µM TSS13841-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 12.46 µM TSS13842-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 6.24 µM TSS13843-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 3.12 µM TSS13844-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 1.6 µM TSS13845-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.8 µM TSS13846-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.39 µM TSS13847-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.2 µM TSS13848-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.1 µM TSS13849-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to oxaliplatin 0.05 µM TSS13949-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 49.99 µM TSS13950-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 24.98 µM TSS13951-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 12.46 µM TSS13952-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 6.24 µM TSS13953-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 3.12 µM TSS13954-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 1.6 µM TSS13955-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.8 µM TSS13956-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.39 µM TSS13957-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.2 µM TSS13958-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.1 µM TSS13959-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to oxaliplatin 0.05 µM
TSP1292 - CMap - NLT_B: Toxicogenomic signatures after exposure to oxaliplatin
Public
https://clue.io/data/NLT#NLT_B
Experimental design
No experimental design provided
Results
No results provided